American Heart Association

Heart Attack And Stroke Symptoms
Volunteer

Login Login
Cart Cart
Contact Us

Sebastien Bonnet

Appearances

DNA Damage Response: Disruption in the Pathogenesis of PAH
State of the Art and Innovative Translational Concepts in Pulmonary Arterial Hypertension
Olaparib is a PARP-targeting therapy for PAH
Novel Therapies for PAH: The next generation of Clinical Trials
Epigenetic and Noncoding RNA Regulation of Pulmonary Vascular Remodeling
Role of Non-Coding RNA in PAH

Sessions-On Demand Technical Inquires:
1-800-501-2303

International Inquiries

*All health/medical information on this website has been reviewed and approved by the American Heart Association, based on scientific research and American Heart Association guidelines. Use this link for more information on our content editorial process.

National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service
1-800-AHA-USA-1
1-800-242-8721
Contact Us

Hours
Mon - Fri: 7AM-9PM CST
Sat - Sun: 9AM-5PM CST

About Us

About the AHA/ASA
Annual Report
AHA Financial Information
Careers
International Programs
Latest Heart and Stroke News
AHA/ASA Media Newsroom

Get Involved

Give
Advocate
Volunteer
SHOP

Our Sites

American Heart Association
American Stroke Association
CPR & ECC
Professional Heart Daily
More Sites

Privacy Policy
Copyright
Ethics Policy
Conflict of Interest Policy
Linking Policy
Diversity
Careers
Suppliers & Providers
Accessibility Statement

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.
The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress ™ DHHS, Go Red ™ AHA ; National Wear Red Day® is a registered trademark.

Health On the Net This site complies with the HONcode Standard for trustworthy health information: verify here.

Shopping Cart

Item	Price	Remove